In order to analyze the roles of some repair genes in the processing of bleomycin-induced DNA damage and, especially, the interrelationships among the involved repair pathways, we investigated the potentially lethal effect of bleomycin on radiosensitive mutants of Saccharomyces cerevisiae defective in recombination, excision, and R4D6-dependent DNA repair. Using single, double, and triple rad mutants, we analyzed growth kinetics and survival curves as a function of bleomycin concentration. Our results indicate that genes belonging to the three epistasis groups interact in the repair of bleomycin-induced DNA damage to different degrees depending on the concentration of bleomycin. The most important mechanisms involved are recombination and postreplication repair. The initial action of a potentially inducible excision repair gene could provide intermediate substrates for the R4D6-and RAD52-dependent repair processes. Interaction between R4D6 and RADS2 genes was epistatic for low bleomycin concentrations. RA1D3 and RAD52 genes act independently in processing DNA damage induced by high concentrations of bleomycin. The synergistic interaction observed at high concentrations in the triple mutant rad2-6 rad6-1 rad52-1 indicates partial independence of the involved repair pathways, with possible common substrates. On the basis of the present results, we propose a heuristic model of bleomycin-induced DNA damage repair.
Bleomycin (BLM) is a radiomimetic glycopeptide antibiotic used extensively in tumor therapy (32, 48) . This drug binds to DNA and through a free-radical-based mechanism produces DNA base loss and single-and double-strand breaks (43, 44) . In different lines of eukaryotic cells, BLM produces inhibition of DNA synthesis (10) as well as cell cycle G2 delay (19, 38) . With phages, bacteria, and yeast cells, it was demonstrated that this drug is recombinogenic and mutagenic (11, 23, 39, 42) . Analysis of BLM-induced mutagenesis in repackaged lambda phage suggests SOS repair dependence (33) .
BLM-induced DNA damage in prokaryotic and eukaryotic cells is partially reparable (3, 22, 27, 40) . For human fibroblasts, a long-patch mode of excision repair of BLM-induced damage was recently described (4, 5) . Using haploid and diploid radiosensitive strains of Saccharomyces cerevisiae, Moore (22) showed that all rad single mutants sensitive to BLM tested, with the exception of rad1S, are sensitive to X rays. Likewise, BLM-sensitive (blm) mutants exhibit crosssensitivity to ionizing radiation and hydrogen peroxide (26) . These results suggest that some aspects of the repair of BLM and ionizing radiation DNA damage in yeast cells may be similar. Furthermore, DNA ligase (the product of the CDC9 gene) is required in the overall process of restoring full-size DNA molecules from DNA fragments produced by BLM (24, 25) .
We have recently shown that BLM induces at least one error-prone type of repair in S. cerevisiae and that the PS04 (XS9) gene acts as a mutation-triggering factor (39) . Furthermore, the combination of UV light and BLM produces different degrees of sensitization depending on dose ranges, suggesting overlapping lesion specificity of the involved repair pathways (excision and recombination) (1) . 
MATERIAL AND METHODS
Yeast strains. The haploid strains of S. cerevisiae used in this study were kindly provided by J. A. P. Henriques. The strains employed were wild-type XV-185-4c (A Ta ade2-1 arg4-17 hisl-7 lysl-l trpS-48 hom3-10 RADW); the single mutants rad2-6, rad3-e5, rad6-1, and rad52-1; the double mutants rad2-6 rad6-1, rad6-1 rad52-1, and rad3-eS rad52-1; and the triple mutant rad2-6 rad6-1 rad52-1. The rad mutants were all derived from crosses of the original mutants with the wild-type strain XV-185-4c. The original source of the rad alleles and phenotypic analysis of all the strains were previously described (14, 29) .
Since suppression of the rad6-1 mutant is frequently observed (20, 37) , UV sensitivity was tested as described by Nunes et al. (30) . We obtained the expected sensitivity for a nonsuppressed rad6-1 strain (20) . Moreover, previously BLM-treated logarithmic and stationary cells of the rad6-1 strain were exposed again to various concentrations of BLM in fresh nutrient liquid medium. Growth curves similar to those shown in Fig. 2A the lack of suppression of the rad6-1 mutant employed in this study.
Media. The liquid medium YED contained 0.5% yeast extract (Difco) and 1% dextrose (Difco). Cells were plated on YED medium (YEDA) solidified by 2% agar (Difco) (30) .
BLM treatments. BLM for clinical use (Kayaku Co. Ltd., Tokyo, Japan) was employed. Stock solutions of BLM were prepared with sterile distilled water. For growth kinetic experiments, BLM was added to liquid YED medium at different concentrations (Bi = 1 pLg/ml, B2 = 3.75 ,g/ml, and B3 = 7.5 ,ug/ml) just before the inoculation of yeast cells. A preliminary test showed that higher concentrations of the drug resulted in complete growth inhibition of all strains under our experimental conditions. For survival experiments, solid YEDA medium containing BLM was prepared according to a previously described method (1, 22, 26 concentrations of the drug (3.75 to 30 ,g/ml) were employed. Although plates were used within 24 h after preparation, similar surviving fractions were obtained with plates used 10 days after preparation. Hence, BLM was stable during the incubation time of the experiments. Independent survival determinations showed that this BLM treatment performed in solid YEDA medium is equivalent to exposing the same cell samples in liquid YED medium containing BLM to continuous agitation for 0.4 h at 30°C and then washing and plating the cells on nutrient YEDA. Growth kinetic assay. Growth was initiated at a cell concentration of 0.5 to 1 x 106 cells per ml by the inoculation of fresh cells (previously grown in YED to early stationary phase) in 10 ml of YED with or without BLM. Cells were grown at 30°C, pH 5.5 ± 0.3, with continuous aeration and agitation. Growth was monitored through counting (by means of a hemocytometer) thenumber of cells per ml (N) as a function of the incubation time. The standard error of the counts was estimated as +4.5% of N. Growth was also monitored by observing the optical density by using the corresponding calibration curves. Data from at least three reproducible experiments are given in the figures.
Surival determinations. Cultures in YED medium were initiated as described above, and cell samples in the mid-log phase of growth (N = 107 cells per ml) were collected, except for the radS2-1 and rad6-1 radS2-1 mutants. Cell samples of both strains in early log phase (N = 3 x 10' cells per ml) were collected, since survival determinations performed during the partial synchronization observed during growth kinetic studies ( Fig. 2B and C) were similar to those of cells in the stationary phase of growth (data not shown). Logarithmic cell samples were diluted appropriately in sterile distilled water to give 200 to 400 viable cells per plate and were promptly spread on YEDA without and with BLM. Plating was performed in quadruplicate at each BLM concentration. Plates were incubated at 30°C for 5 to 10 days. Data from three to six experiments are given, and 95% binomial confidence limits are included in the figures.
RESULTS
Growth kinetics of cell populations. The growth curves of haploid yeast cell populations of wild-type RAD+ and single, double, and triple rad mutants in liquid YED medium without and with BLM are shown in Fig. 1 to 4 . The number of cells per ml (N) versus time (t) was plotted on semi-log coordinates. For simplicity, experimental points were plotted up to 35 h, since no further modification in growth thereafter was observed. To analyze these growth curves quantitatively, the following kinetic parameters were calculated: the maximal number of cells per ml reached in the stationary phase of growth (Nm.), the doubling time of the population (Dl) during the exponential phase of growth, and the lag phase time (tlag), which corresponds to the mean time elapsed before the onset of cell division. Table 1 summarizes the growth kinetic parameters of the strains studied cultured without BLM and in the presence of various concentrations of the drug (B2 = 3.75 ,ug/ml and B3 = 7.5 ,g/ml).
Differences among growth kinetic parameters of strains cultured without BLM (control samples), most probably due to different genetic backgrounds, were observed (Table 1) . Hence, the growth kinetics of each strain cultured with BLM were compared with the corresponding values of the control without BLM treatment. The observed DT values of all studied strains were in accordance with those reported previously (18) . As described in Materials and Methods, results indicated the lack of suppression of the rad6-1 mutation. The radS2-1 and the rad6-1 radS2-1 mutants exhibited partial synchronization in the log phase of growth, thereafter growing at the same rate until entering the stationary phase (Fig. 2B and C) . The reason for this partial synchronization is unknown.
The growth kinetics of all strains used in this study were modified to different degrees by continuous exposure of the strains to various concentrations of BLM. The most sensitive strain was the triple mutant rad2-6 rad6-1 radS2-1, since it showed no growth at any BLM concentration tested (Fig.  2D) (3.75 ,ug/ml) and B3 (7.5 ,ug/ml), and it was modified at Bi (1 ,ug/ml) ( Fig. 2B and C) . At the latter BLM concentration, the rad6-1 rad52-1 double mutant showed a twofold increase in the DT and both mutants exhibited a 50% decrease in the NmaX and no variation in the tlag. Interestingly, in the presence of the drug, partial synchronization was not observed. The growth kinetics of the other strains studied were significantly modified at B2 and B3 (Fig. 1, 2A, 3, and 4) . In fact, analysis of the kinetic parameters showed an increase in the DT and a decrease in the Nmax (Table 1 ). An increase in the t1 as a function of BLM concentration was observed with wild-type RAD+ (Fig. 1) and with all mutant strains that exhibited growth ( Fig. 2A, 3, and 4 ). This increase was more significant in the rad3-eS rad52-1 double mutant (14-fold at B2) (Fig. 3B) and in the rad6-1 single mutant (6-fold at B3) ( Fig. 2A) (Fig. 6) . The rad2-6 rad6-1 double mutant was highly resistant, since no difference in survival with respect to the RAD+ strain and the rad2-6 mutant was observed (Fig. 7) . Among the examined strains, the triple mutant rad2-6 rad6-1 radS2-1 showed the highest level of BLM sensitivity, especially at high concentrations of the 7, rad3-eS; +, rad6-1; 0, radS2-1.
drug (Fig. 6 ). In this case, the observed interaction was synergistic.
For high BLM concentrations, the sensitivity of the double mutant involving the RAD3 and RAD52 genes exhibited additivity of the sensitivities of the corresponding single mutant genes (Fig. 8) .
DISCUSSION
Present results show that BLM-induced lethal DNA damage is processed by the recombinational, RAD6-dependent, and excisional repair mechanisms. The function of the known epistasis groups (8, 9, 12, 13 ) is dynamic and depends on the BLM concentration range. According to survival and growth kinetic analysis, at low BLM concentrations (O c BLM < 15 ,ug/ml) the most important gene involved in the repair of potentially lethal damage is RAD52, whereas for high BLM concentrations (15 p,g/ml < BLM < 30 ,ug/ml), the RAD6 gene plays the most important role. It must be emphasized that the survival curves were obtained by plating on increasing concentrations of BLM, and therefore the results may not be strictly comparable to those of experiments in which treatment is given briefly and then ended.
It is noteworthy that all strains studied except rad6-1 exhibited biphasic survival curves with a resistant second component ( Fig. 5 through 8 ). Mammalian cells also show biphasic survival curves with BLM (6, 47) . This biphasic response could be due to the induction of repair enzymes. Interestingly, in our laboratory it has been recently shown that the resistant component of these curves depends at least in part on BLM-inducible repair (39) . Moreover, the RAD6 gene is induced by DNA damage during the log phase of growth (21) . Other The exponential survival curve of the rad6-1 mutant as well as the significant increase in the tiag ( Fig. 2A and 5 ) could be related not only to RAD6 postreplication repair activities (20, 34, 41) but also to its regulatory functions (20, 21, 41) .
The fact that the growth of the radS2-1 mutant under continuous exposure to BLM is either defective or completely blocked (Fig. 2B) , as well as its sensitivity with low BLM concentrations (Fig. 5) breaks. These include X rays (15, 35) , neocarzinostatin (28) , and phleomycin (24) . Regarding the excision-defective mutants studied, growth kinetic parameters of rad2-6 and rad3-eS showed minor modifications upon BLM treatment. The latter is partially inhibited at 7.5 ,g of BLM per ml (Table 1 ; Fig. 3A and 4A) . Moreover, high survival with BLM was observed with both mutants (Fig. 5) . These facts indicate a low input flow through the corresponding excision pathway in the presence of other functioning repair processes. Since the RAD3 product has DNA helicase and ATPase activities (45, 46) , this gene could have an accessory role in the repair of BLM damage, perhaps by unwinding the DNA duplex during repair.
Concerning interactions among repair processes (8, 9, 12, 13, 18) , our results showed epistasis between the RAD6 and RADS2 genes at low BLM concentrations. In fact, according to results obtained by other authors, RAD6 functions represent an earlier step required for repair, mutagenesis, recombination, and meiosis (16, 21, 41) . RAD6 and RADS2 gene products acting on the same repair pathway were also reported in studies with the antitumoral agent BD-40 (29) .
For high BLM concentrations, rad6-1 radS2-1 as well as rad2-6 rad6-1 double mutants displayed significantly higher rates of survival than the rad6-1 single mutant ( Fig. 6 and 7 ). This resistance could be explained by the function of alternative repair pathways. Indeed, in the double mutant rad2-6 rad6-1, repair of BLM-induced damage could take place through the recombinational pathway. Recent 0, rad52-1; A, rad3-e5 radS2-1.
repair pathway. For the rad6-1 radS2-1 double mutant, suppression of the rad6 mutation seems less probable, since it depends on the RA4DS2 recombinational pathway and the excision repair pathway is not required (37) . The difference between the survival rate of the rad6-1 radS2-1 double mutant and that of the triple mutant rad2-6 rad6-1 rad52-1 is a measure of repair due to the RAD2 gene product. It has been shown that the RAD2 gene is inducible by BLM (36) . In consequence, we could speculate that the relatively high resistance of the double mutant rad6-1 radS2-1 is due to the initial action of the potentially inducible RAD2 gene, which could provide intermediate substrates to be processed by later steps of the repair pathways. In this context, the RAD24 gene is involved in excision as well as in recombination repair of UV and X-ray damage (7) . XS genes (XS6, XS8, and XS9 = PS04) are also involved in both types of repair (13, 30) . Although differential repair is the most likely explanation for the results, it is not the only one possible. The high rates of survival for both double mutants could also be explained by leakiness of the corresponding mutations, genetic factors varying between the strains (e.g., auxotrophic alleles), as well as differences in their abilities to take up or metabolize BLM. Additive interaction between the RAD3 and RADS2 genes at high BLM concentrations (Fig. 8) indicates the independence of these repair processes. A similar type of interaction was described for UV irradiation (2) .
The combination of rad2, rad6, and radS2 mutations confers synergistic inactivation (Fig. 7) , indicating independence and possible common substrates of the involved repair processes. Interestingly, recent evidence indicates that the expression of DNA repair genes belonging to these three different epistasis groups is independently regulated (17) .
We propose a model according to the facts discussed above that describes DNA repair of BLM-induced damage (Fig. 9) . Heuristic model of DNA repair pathways according to the present results. BLM-induced DNA damage (strand breaks and base loss) can be processed by the excision, recombinational, and RAD6-dependent repair pathways. The magnitude of repair fluxes depends on BLM concentration. The RAD52 gene product plays a central role at low concentrations of this drug, whereas at high concentrations, the RAD6 product is more important in processing BLM-induced DNA damage. The arrowheads in the RAD6 group represent different categories of loci dependent on the RAD6 gene. Upon the mutation of RAD2 and RAD6 genes, repair could take place through the recombinational pathway. The initial action of a potentially inducible repair gene could provide intermediate substrates to the RAD6-and RAD52-dependent repair processes. RAD3 and RAD52 genes are independent in processing DNA damage induced by high BLM concentrations. These three main repair processes are partially independent, with possible common steps and substrates.
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